Amphastar Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMPH and other ETFs, options, and stocks.

About AMPH

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. 

CEO
Yong Feng Zhang
CEOYong Feng Zhang
Employees
2,028
Employees2,028
Headquarters
Rancho Cucamonga, California
HeadquartersRancho Cucamonga, California
Founded
1996
Founded1996
Employees
2,028
Employees2,028

AMPH Key Statistics

Market cap
1.25B
Market cap1.25B
Price-Earnings ratio
12.23
Price-Earnings ratio12.23
Dividend yield
Dividend yield
Average volume
362.75K
Average volume362.75K
High today
$27.84
High today$27.84
Low today
$26.97
Low today$26.97
Open price
$27.58
Open price$27.58
Volume
394.33K
Volume394.33K
52 Week high
$45.39
52 Week high$45.39
52 Week low
$20.39
52 Week low$20.39

Stock Snapshot

As of today, Amphastar Pharmaceuticals(AMPH) shares are valued at $27.15. The company's market cap stands at 1.25B, with a P/E ratio of 12.23.

On 2025-12-04, Amphastar Pharmaceuticals(AMPH) stock traded between a low of $26.97 and a high of $27.84. Shares are currently priced at $27.15, which is +0.7% above the low and -2.5% below the high.

The Amphastar Pharmaceuticals(AMPH)'s current trading volume is 394.33K, compared to an average daily volume of 362.75K.

During the past year, Amphastar Pharmaceuticals(AMPH) stock moved between $20.39 at its lowest and $45.39 at its peak.

During the past year, Amphastar Pharmaceuticals(AMPH) stock moved between $20.39 at its lowest and $45.39 at its peak.

AMPH News

Simply Wall St 5d
Amphastar Pharmaceuticals Is Up 6.5% After Earnings Beat and Pipeline Expansion—What's Changed?

Amphastar Pharmaceuticals recently reported third-quarter earnings that exceeded analyst forecasts, with net revenues of US$191.8 million and adjusted net incom...

Amphastar Pharmaceuticals Is Up 6.5% After Earnings Beat and Pipeline Expansion—What's Changed?
Simply Wall St 6d
A Look at Amphastar Pharmaceuticals’s Valuation After Upbeat Earnings and Strategic Pipeline Moves

Amphastar Pharmaceuticals (AMPH) delivered upbeat quarterly results, surprising the market with earnings that surpassed forecasts. Investors are also watching t...

A Look at Amphastar Pharmaceuticals’s Valuation After Upbeat Earnings and Strategic Pipeline Moves

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own AMPH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.